1. Home
  2. PNNT vs TECX Comparison

PNNT vs TECX Comparison

Compare PNNT & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNNT
  • TECX
  • Stock Information
  • Founded
  • PNNT 2007
  • TECX 2019
  • Country
  • PNNT United States
  • TECX United States
  • Employees
  • PNNT N/A
  • TECX 51
  • Industry
  • PNNT Finance: Consumer Services
  • TECX
  • Sector
  • PNNT Finance
  • TECX
  • Exchange
  • PNNT Nasdaq
  • TECX Nasdaq
  • Market Cap
  • PNNT 442.7M
  • TECX 420.5M
  • IPO Year
  • PNNT 2007
  • TECX 2018
  • Fundamental
  • Price
  • PNNT $7.23
  • TECX $22.19
  • Analyst Decision
  • PNNT Sell
  • TECX Strong Buy
  • Analyst Count
  • PNNT 3
  • TECX 5
  • Target Price
  • PNNT $5.88
  • TECX $79.00
  • AVG Volume (30 Days)
  • PNNT 425.7K
  • TECX 187.7K
  • Earning Date
  • PNNT 08-11-2025
  • TECX 08-13-2025
  • Dividend Yield
  • PNNT 13.28%
  • TECX N/A
  • EPS Growth
  • PNNT N/A
  • TECX N/A
  • EPS
  • PNNT 0.73
  • TECX N/A
  • Revenue
  • PNNT $138,371,000.00
  • TECX N/A
  • Revenue This Year
  • PNNT N/A
  • TECX N/A
  • Revenue Next Year
  • PNNT N/A
  • TECX N/A
  • P/E Ratio
  • PNNT $9.90
  • TECX N/A
  • Revenue Growth
  • PNNT N/A
  • TECX N/A
  • 52 Week Low
  • PNNT $5.72
  • TECX $13.70
  • 52 Week High
  • PNNT $7.45
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • PNNT 55.71
  • TECX 51.47
  • Support Level
  • PNNT $7.14
  • TECX $21.99
  • Resistance Level
  • PNNT $7.45
  • TECX $23.25
  • Average True Range (ATR)
  • PNNT 0.11
  • TECX 1.52
  • MACD
  • PNNT -0.02
  • TECX -0.00
  • Stochastic Oscillator
  • PNNT 33.33
  • TECX 46.70

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: